A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors
A phase 1/2 trial of Purinostat in advanced solid tumours, run by Chengdu Zenitar Biomedical Technology Co., Ltd, now recruiting.
Overview
A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06431243 by Chengdu Zenitar Biomedical Technology Co., Ltd, with 132 participants planned, started 2024-05-08 and due to reach its primary completion in 2026-05-01. Interventions recorded: A0/B0 group Purinostat Mesylate 11.2mg/m2, A0/B0 group Purinostat Mesylate 15mg/m2, A group Purinostat Mesylate 6mg/m2, A group Purinostat Mesylate 8.4mg/m2, A group Purinostat Mesylate 11.2mg/m2 and A group Purinostat Mesylate 15 mg/m2.
Similar pages
not linked directly; found by shared links- TrialPurinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Shares Purinostat, Chengdu Zenitar Biomedical Technology and the tag pipeline.
- TrialA Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Shares Purinostat, Chengdu Zenitar Biomedical Technology and the tag pipeline.
- TrialStudy of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
Shares Chengdu Zenitar Biomedical Technology and the tag pipeline.
- TrialA Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
- TrialPhase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
Shares Chengdu Zenitar Biomedical Technology and the tag pipeline.
- TrialInvestigation of a Therapeutic Vaccine (ACIT-1) in Cancer
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPlasmodium Immunotherapy for Advanced Malignant Solid Tumors
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialFirst-in-Human Study of ICT01 in Patients With Advanced Cancer
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.